Quantitation of left ventricular volumes and ejection fraction in post-infarction patients from biplane and single plane two-dimensional echocardiograms

European Heart Journal

Volumn 19, Issue 5, 1998, Pages 808-816

  St John Sutton, Martin ^a   Otterstat, J E ^b   Plappert, T ^a   Parker, A ^c   Sekarski, D ^c   Keane, M G ^a   Poole Wilson, P ^d   Lubsen, K ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Vestfold Hospital   (Norway)

^c SOCAR SA   (Switzerland)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Echocardiography; Ejection fraction; Left ventricular volumes

Indexed keywords

ALGORITHM; ARTICLE; CALCULATION; CLINICAL TRIAL; ECHOCARDIOGRAPHY; HEART DILATATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE VOLUME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; CARDIAC VOLUME; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NISOLDIPINE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0032080505     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0852     Document Type: Article

References (15)

1. [1] The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685-91.
2. [2] Greenberg B, Quinones MA, Koilpillai C et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD Echocardiography Substudy. Circulation 1995; 91: 2573-81.
3. [3] The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-8.
4. [4] St John Sutton M, Pfeffer MA, Plappert T et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation 1994; 89: 68-75.
5. [5] Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332: 80-5.
6. [6] Kingma JH, van Gilst WH, Peels CH, Dambrink J-HE, Verheught FWA, Wielenga RP for the CATS Investigators. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study (CATS). Eur Heart J 1994; 15: 898-907.
7. [7] van Gilst WH, Kingma JH, Peels KH, Dambrink HE, St John Sutton M. Which patient benefits from early angiotensin converting enzyme inhibition after myocardial infarction? Results of One-Year Serial Echocardiographic Follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol 1996; 28: 114-21.
8. [8] Marino P, Zanolla L, Zardini P. Effect of streptokinase on left ventricular remodeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. J Am Coll Cardiol 1989; 14: 1149-58.
9. [9] Nicolosi GL, Latini R, Marino P et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction: the GISSI-3 trial. Eur Heart J 1996; 16: 1646-56.
10. [10] Gruppo Italiano per lo Studio della Sopravivenza nell'Infarto miocardico. GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.
11. [11] The Defiant Research Group (Doppler Flow and Echocardiography in Functional cardiac Insufficiency Assessment of Nisoldipine Therapy). Improved diastolic function with the calcium antagonist nisoldipine (core-coated) in patients post myocardial infarction: results of the DEFIANT Study. Eur Heart J 1992; 13: 1496-505.
12. [12] Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards Subcommittee on Quantitation of Two-Dimensional Echocardiography. J Am Soc Echocardiogr 1989; 2: 358-67.
13. [13] The DEFIANT-II Research Group. Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. Eur Heart J 1997; 18: 31-40.
14. [14] Albin G, Rahko PS. Comparison of echocardiographic quantitation of left ventricular ejection fraction to radionuclide angiography in patients with regional wall motion abnormalities. Am J Cardiol 1990; 65: 1031-2.
15. [15] Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA. Left ventricular remodeling in the year after first anterior myocar-dial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992; 19: 1136-44.